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Abstract: Approximately 15% of the Western world population, including pregnant women and their
children, is characterized as vitamin C (vitC) deficient. In guinea pigs, early life vitC deficiency causes
spatial memory deficits, decreased hippocampal volume and neuron numbers, in otherwise clinically
healthy animals. We hypothesized that vitC deficiency leads to decreased brain-derived neurotrophic
factor and synaptic plasticity markers in selected brain areas (frontal cortex, hippocampus and striatum)
and cause morphological changes in cornu ammonis 1 pyramidal neurons of the hippocampus either
through a direct effect or indirectly by increased oxidative stress. Fifty-seven female guinea pigs were
allocated to three groups receiving either 1390, 100 or 0–50 mg vitC/kg feed for 11 weeks. Dietary
vitC levels were reflected in the plasma, cortical and adrenal gland levels, however, redox imbalance
was only present in the adrenal glands allowing for the investigation of a direct influence of vitC
deficiency on the chosen parameters in the brain. Synaptic plasticity markers were not affected in the
investigated brain areas and no differences in isolated pyramidal neuron morphology was recorded.
Based on our findings, it appears that vitC deficiency may primarily elicit impaired neuronal function
through increased levels of oxidative stress.
Keywords: vitamin C deficiency; cavia porcellus; neuronal morphology; synaptic plasticity
1. Introduction
The developing brain is particularly susceptible to oxidative stress due to a high cellular metabolic
activity and immature antioxidant systems [1–3]. During this sensitive period, malnutrition has been
shown to elicit a negative impact on cognitive function, brain morphology, neuronal development and
maturation [4–6]. In the Western world, vitamin C (vitC) deficiency is relatively common, with an
estimated prevalence of about 15% [7–9], including pregnant women and children [10–12]. VitC is an
essential micronutrient with strong antioxidant properties and the brain displays surprisingly high
levels in comparison with other organs [13,14]. During prolonged depletion of dietary vitC, the levels in
the brain only decline to approximately 25% of saturated levels, despite close to total exhaustion in most
other organs, emphasizing the brain’s unique ability to preserve high vitC levels [15,16]. In addition to
being an efficient quencher of free radicals, vitC is also a specific co-factor in several cellular pathways
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e.g., the recycling of tetrahydrobiopterin (BH4), involved in the synthesis of the monoaminergic
neurotransmitters, and acts as a key participant in glutamatergic neurotransmission/glutamate
re-uptake [17–19].
In guinea pigs, early life vitC deficiency increases oxidative stress in the brain resulting in spatial
memory deficits, reduced hippocampal volume and neuron numbers, as well as a suggested decrease
in neuronal migration in the dentate gyrus [16,20–22]. Furthermore, vitC transport to the brain is
essential for perinatal survival in mice [23,24], and induced deficiency has been shown to reduce
functional performance in the L-gulono-γ-lactone oxidase knockout mice (Gulo−/−) [25,26]. These
studies stress the importance of vitC in the brain and highlight the negative consequences of deficiency
during cerebral development; however, the underlying mechanisms behind vitC deficiency promoted
deficits in the brain are currently not sufficiently elucidated.
Synaptic plasticity and dendrite development are key neuronal features in memory
formation [27–30]. VitC supplementation to in vitro cultured neurons exposed to a peroxide insult
induces brain derived neurotrophic factor (BDNF) [31], while total cessation of vitC supplementation
leads to increased oxidative stress and decreased BDNF in the brain in vivo [32]. In the developing
brain, BDNF is an important growth factor promoting neuronal survival, dendrite development
and synaptic plasticity [33], and plays an essential role in memory formation, including spatial
memory [33,34]. Thus, perturbation of the BDNF pathway may be an important contributor to the
dysfunctions in spatial memory reported in marginally vitC deficient guinea pigs [20]. This may
be by the direct influence of low vitC on BDNF or secondarily through increased oxidative stress.
In addition, the active uptake of reduced vitC, ascorbate (Asc) in neurons, achieved through the
sodium-dependent vitC transporter 2 (SVCT2), has been shown to be important for neuronal
maturation, glutamatergic function, and dendrite morphology and complexity [35–37], highlighting
another, potentially direct, effect of vitC deficiency on synaptic plasticity, dendrite development and
subsequent neuronal signaling.
The current study investigated the hypothesis that early life vitC deficiency increases oxidative
stress and decreases the levels of BDNF in the frontal cortex (FC), the hippocampus (Hip) and
the striatum (Stri), which are all regions that are interconnected and involved in spatial memory,
motor function, goal-directed behavior and decision making [38–40] (Figure 1). Decreased levels
of BDNF may decrease protein levels and/or phosphorylation of downstream molecular markers
Ca2+-calmodulin-dependent kinase II (CAMKII) and synapsin 1, promoting negative effects on synaptic
plasticity, dendrite development and neurotransmission [3,41]. Furthermore, vitC deficiency might
decrease signal transmission and spatial memory formation by reducing arborization and dendritic
spine development of the hippocampal cornu ammonis 1 (CA1) pyramidal neurons, known to be
vulnerable to oxidative stress, [42–45]. Two different degrees of vitC deficiency were compared to
controls receiving high levels of vitC, enabling the assessment of a putative dose-related response on
the investigated markers.
Nutrients 2018, 10, 749 3 of 18
Nutrients 2018, 10, x FOR PEER REVIEW  3 of 18 
 
 
Figure 1. Hypothesized pathways through which vitamin C (vitC) deficiency may cause functional 
deficits in the brain. Reduced levels of vitC during deficiency may disturb redox balance and 
subsequently promote oxidative stress in the brain. In addition, vitC deficiency may exert a direct 
effect on brain function. Both vitC deficiency and increases in oxidative stress have been found to 
lower levels of brain-derived neurotrophic factor (BDNF) in the brain. A decrease in BDNF, and 
subsequent negative effects on downstream pathways, may reduce synaptic plasticity. Synaptic 
plasticity is crucial in memory formation and cognitive functions; hence, dysfunction may lower 
signal transmission and induce functional deficits. BDNF is also involved in neuronal arbor growth 
and a reduction may further induce aberrant dendrite development of hippocampal cornu ammonis 
(CA) 1 pyramidal neurons. These neurons are crucial in memory functions and have been found to 
be susceptible to increased oxidative stress and states of malnutrition. Collectively, vitC deficiency is 
hypothesized to cause changes in synaptic plasticity and neuronal morphology, potentially 
disrupting brain functionality. 
2. Materials and Methods 
2.1. Animals 
All in vivo experiments were approved by the Danish Animal Experiments Inspectorate (License 
number 2012-15-2934-00205) under the Ministry of Environment and Food and in accordance with 
EU directive 2010/63/EU and approved by the Animal Care and Use Committee (IACUC, University 
of Copenhagen, Faculty of Health Sciences) on 11 March 2016 (project number P16-210). All animals 
were inspected daily by trained personnel and group-housed in floor pens with ad libitum access to 
feed, hay and water. In total, 57 female Dunkin Hartley guinea pigs (Envigo, Venray, The 
Netherlands) at seven days of age were weight-stratified into three dietary groups (n = 19/group) 
receiving a standard guinea pig maintenance chow (prod. code S9406; ssniff Spezialdiäten GmbH, 
Soest, Germany) differing only in vitC content. The vitC was added as phosphorylated ascorbate 
(Stay-C) to extend stability. The total ascorbate content of the feed was subsequently determined by 
post production analysis. The respective experimental groups received: 1390 mg vitC/kg feed by 
analysis (Ctrl), 100 mg vitC/kg feed (Def) and 0–50 mg vitC/kg feed (Sev_def) (ssniff Spezialdiäten 
GmbH, Soest, Germany). The levels of 100 and 50 mg vitC/kg feed were obtained by titration of 123 
mg vitC/kg feed (by analysis) with 0 mg vitC/kg feed. The Sev_def group was kept on 0 mg vitC/kg 
feed for 16 days, until the first animals showed signs of weight stagnation (a pre-scorbutic clinical 
sign) after which the entire group was immediately transferred to 50 mg vitC/kg feed. Three Sev_def 
animals received an oral dose of softened vitC containing feed on day 16 and 17 to alleviate pre-
scorbutic symptoms. The vitC levels of the Ctrl and Def diets were based on previously published 
data, ensuring vitC levels in Ctrl and low, albeit non-scorbutic levels in Def animals [13,20,21]. The 
Sev_def group was included in the study to increase effects of low vitC by first inducing a severe, 
borderline scorbutic vitC deficiency through total dietary depletion and subsequently keeping the 
animals on a low but non-scorbutic vitC containing diet. All animals were weight-monitored weekly, 
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deficits in the brain. Reduced levels of vitC during deficiency may disturb redox balance and
subsequently promote oxidative stress in the brain. In addition, vitC deficiency may exert a direct effect
on brain function. Both vitC deficiency and increases in oxidative stress have been found to lower
levels of brain-derived neurotrophic factor (BDNF) in the brain. A decrease in BDNF, and subsequent
negative effects on downstream path ays, may reduce synaptic plasticity. Synaptic plasticity is crucial
in memory formation and cognitive functions; hence, dysfunction may lower signal transmission and
induce functional deficits. BDNF is also involved in neuronal arbor growth and a reduction may further
induce aberrant dendrite development of hippocampal cornu amm nis (CA) 1 yramidal neur s.
These neurons are cr cial in memory fu ctions and have been found to be susceptible to increased
oxidative str ss a d states of malnutrition. Collectively, vitC deficiency is hypothesized to cause
changes in synapti plasti ity and neuronal morphology, potentially disrupting brain functi nality.
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All in vivo experiments were approved by the Danish Animal Experiments Inspectorate (License
number 2012-15-2934-00205) und r the Ministry of Environment nd Food and in accordanc with EU
directive 2010/63/EU and approved by the Animal Care and Use Committee (IACUC, University of
Copenhagen, Faculty of Health Sciences) on 11 March 2016 (project number P16-210). All animals were
inspected daily by trained personnel and gr up-housed in floor pens with ad libitum access to feed,
hay and wat r. In total, 57 female Dunkin Hartley guinea pigs (Envigo, Venray, The Netherland ) at
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animals show signs of weight stagnation (a pre-scorbutic clinical sign) after which the entire group
was immediately transferred to 50 g vitC/kg feed. Three Sev_def a imals received an oral dose of
oftened vitC containing f ed n day 16 and 17 to alleviate pr -sc rbutic symptoms. The vitC levels of
the Ctrl and Def diets were based on previously published data, ensuring vitC levels in Ctrl nd low,
albeit non-scorbutic levels in Def animals [13,20,21]. Th Sev_def group was i cluded in the study to
increase effects of low itC by first i ucing severe, borderline scorbutic vitC deficiency through total
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dietary depletion and subsequently keeping the animals on a low but non-scorbutic vitC containing
diet. All animals were weight-monitored weekly, except for Sev_def animals, which were weighed
every other day during the first 16 days. Apart from the three Sev_def animals which were briefly
treated for symptoms of scurvy to a full recovery, no other clinical signs of decreased animal welfare
were recorded during the study period.
After 11 weeks on the diet, the animals were sedated with 0.2 mL/kg butorphanol (Torbugesic,
Scanvet, Fredensborg, Denmark) and anaesthetized with 3–5% isoflurane (Isoba Vet, Intervet
International, Boxmeer, The Netherlands), until cessation of voluntary reflexes after which
an intra-cardiac blood sample was obtained and plasma subsequently collected as previously
described [46]. The animals were euthanized by decapitation and the brains were removed, rinsed
in ice-cold PBS, weighed and divided into hemispheres. The right hemispheres from 27 randomly
chosen animals were allocated to another study. For the remaining 30 animals, the right hemispheres
from Ctrl and Sev_def were preserved for the Golgi-analysis, while the right hemispheres from the
Def group were not included in this part of the study. The left hemispheres from all animals in the
three groups were divided into FC, Hip, Stri (defined by anatomical fix-points with reference to the
rat brain [47]) and the residual cerebral cortex, and immediately snap-frozen in liquid nitrogen. The
adrenal glands were removed, rinsed in PBS; the left was snap-frozen in liquid nitrogen and the right
fixated in 4% paraformaldehyde for future analysis.
2.2. Biochemistry
Plasma levels of total vitC, dehydroascorbate (DHA), malondialdehyde (MDA), α- and
γ-tocopherol, BH4 and dihydrobiopterin (BH2) were measured. In tissue samples, the residual
cerebral cortex and adrenal gland, analyses of vitC, DHA, glutathione (GSH), glutathione disulfide
(GSSG), superoxide dismutase (SOD), MDA (not adrenal glands), α- and γ-tocopherol were conducted.
Both plasma and tissue samples were analyzed as previously described [22,46,48–50].
Briefly, plasma samples for total vitC and DHA were stabilized 1:2 with 10% meta-phosphoric
acid and analyzed by electrochemical detection on HPLC. DHA% was calculated as the percentage
of total vitC, which constitutes DHA. MDA was measured by fluorometric detection on HPLC.
BH4 was stabilized with 4% dithioerythritol and quantified by fluorometric detection on HPLC.
For tissue samples the tissue was homogenized 1:10 in PBS and for total vitC, DHA, GSH and GSSG,
the samples were stabilized 1:2 with 10% meta-phosphoric acid. GSH and GSSG were measured using
spectrofluorometry and vitC and DHA by electrochemical detection on HPLC. For SOD, a Ransod kit
was used. α- and γ-tocopherol were measured by HPLC using electrochemical detection.
2.3. Protein Extraction
The protein extraction was performed on ten randomly chosen animals from each group as
previously described [51]. Briefly, 40 mg of tissue from each of FC, Hip and Stri was dissected on ice.
The tissue samples were homogenized using a Potter–Elvehjem in 500 µL RIPA buffer (50 mmol/L tris
pH 8.0, 150 mmol/L sodium chloride, 1% Triton X-100, 0.5% sodium deoxycholate and 0.1% sodium
dodecyl sulfate) with 1:100 protease inhibitor cocktail (Sigma-Aldrich, Darmstadt, Germany) and 1:100
phosphatase inhibitor cocktail (Sigma-Aldrich, Darmstadt, Germany). The samples were centrifuged
for 10 min at 12,000 rpm at 4 ◦C and the protein extract was stored at −80 ◦C in aliquots. Protein
concentration was determined by a commercial BCA kit according to manufacturer’s instructions
(Merck Millipore, Darmstadt, Germany).
2.4. ELISA
BDNF levels were analyzed in FC, Hip and Stri using a commercial ELISA kit (SEA011Gu,
Cloud-Clone Corp, Houston, TX, USA) as instructed by the manufacturer. All samples were diluted
1:20 in sterile PBS as determined by a dilution series to obtain an optical density close to the center
of the linear part of the standard curve. All results were normalized to protein concentration. Four
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animals across all three groups had to be excluded from the FC analysis and three from the Hip for
technical reasons.
2.5. Western Blotting
Ten µg of protein from each of FC, Hip and Stri were adjusted to a volume of 11.25 µL, before
adding 3.75 µL Laemmli buffer (Bio Rad, Hercules, CA, USA) with 1:10 mecaptoethanol (Sigma-Aldrich,
Darmstadt, Germany). The samples were denatured at 70 ◦C for 10 min before transfer to a 7.5%
Criterion™ TGX™ Precast Midi Protein Gel, 26 well, 15 µL/well (Bio Rad, Hercules, CA, USA) and the
electrophoresis was run for approximately 40 min. Afterwards the proteins were transferred to a PVDF
membrane [51]. All samples were run in duplicates and normalized to total protein levels (REVERT™
Total Protein Stain, Li-Cor, Lincoln, NE, USA). The following antibodies were applied: Anti-synapsin 1
(ab8, Abcam, Cambridge, United Kingdom; 1:1000); anti-CAMKII (Cba-2, Thermo Scientific, Waltham,
MA, USA; 1:4000); anti-phosphorylated CAMKII (p-CAMKII) (22B1, Thermo Scientific, Waltham, MA,
USA; 1:1000); anti-phosphorylated synapsin 1 (p-synapsin 1) (NB300-181, Novus Biologicals, Littleton,
CO, USA; 1:1000). All primary antibodies were incubated at 4 ◦C o/n. As secondary IRDye® 800CW
Donkey-anti-Rabbit IgG (Li-Cor, Lincoln, NE, USA; 1:15,000) and IRDye® 680RD Donkey-anti-Mouse
IgG (Li-Cor, Lincoln, NE, USA; 1:15,000) were applied for one hour at RT. The analyses were done
using Image Studio 5.2 (Li-Cor, Lincoln, NE, USA) by an observer blinded to the experimental group.
Examples of Western blots positive for the selected markers, are provided in Figure 2.
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manufacturer’s instructions [52]. In summary: The hemispheres were stored in A + B solution for 14 
days with a solution change after 24 h and then transferred to C solution for seven days with a 
solution change after 24 h. The hemispheres were then snap-frozen in isopropanol and stored at −80 
°C until further processing. 
The hemispheres were mounted on a HM 569 M Cryostat (Mikrom, Walldorf, Germany) and the 
Hip was cut into 200 μm coronal sections in its entirety. The sections were mounted on 2% gelatin-
coated slides and left to dry for one hour at RT after which they were rinsed in miliQ water and 
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microscope (Olympus Optical co., LTD., Tokyo, Japan) and 60X oil objective (PlanApo, NA 1.40, Oil, 
Olympus, Japan) applying a step size of 1 μm [52,53]. Neurons were preferentially selected with the 
soma situated in the middle of the z-axis of the section (between 80 and 150 μm post-dehydration). 
Figure 2. Examples of Western blots of p-/synapsin 1 and p-/Ca2+-calmodulin-dependent kinase II.
The figure depicts examples of the Western blots of the four synaptic plasticity markers investigated.
The two bands seen in the p-synapsin and synapsin Western blots (70 and 74 kDa respectively) are
consistent with splice variants as confirmed by manufacturer. P-CAMKII and CAMKII were detected
around 50 kDa in accordance with previous findings.
2.6. Golgi-Staining and Section Processing
Only Ctrl and Sev_def animals were used for the Golgi-staining and 3D reconstruction of neurons.
To Golgi-stain the right hemispheres, a commercial kit was purchased (FD Rapid GolgiStain™, FD
NeuroTechnologies, Inc., Colombia, MD, USA) and the staining performed as per manufacturer’s
instructions [52]. In summary: The hemispheres were stored in A + B solution for 14 days with
a solution change after 24 h and then transferred to C solution for seven days with a solution
change after 24 h. The hemispheres were then snap-frozen in isopropanol and stored at −80 ◦C
until further processing.
The hemispheres were mounted on a HM 569 M Cryostat (Mikrom, Walldorf, Germany) and
the Hip was cut into 200 µm coronal sections in its entirety. The sections were mounted on 2%
gelatin-coated slides and left to dry for one hour at RT after which they were rinsed in miliQ water
and placed in D + E solution for 10 min, before being dehydrated in alcohol, cleared in xylene and
cover slipped.
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2.7. Image Acquisition and Analysis
Z-stacks of neurons with somas lying within the stratum pyramidale of the CA1 area of the
Hip were captured with newCAST, VIS (Visiopharm, Hoersholm, Denmark) using Olympus BX50F
microscope (Olympus Optical co., LTD., Tokyo, Japan) and 60X oil objective (PlanApo, NA 1.40, Oil,
Olympus, Japan) applying a step size of 1 µm [52,53]. Neurons were preferentially selected with the
soma situated in the middle of the z-axis of the section (between 80 and 150 µm post-dehydration).
To reconstruct and analyze the neurons the automatic filament tracer in Imaris (Bitplane, Zürich,
Switzerland) was applied. From each animal, five to seven apical and basal dendritic trees, respectively,
were analyzed and averaged by an observer blinded to the experimental group [52,53]. The Sholl
analysis was conducted in the program by concentric circles with a radius difference of 20 µm radiating
from the center of the soma [52]. An overview of the measured morphological parameters and the
expected outcome of vitC deficiency is shown in Table 1.
Table 1. Parameters included in the morphological analysis of cornu ammonis 1 pyramidal neurons.
Vitamin C deficiency was expected to cause aberrant neuron morphology either directly or through
subsequent oxidative stress thereby decreasing dendrite branching and length of cornu ammonis 1
pyramidal neurons causing an overall decrease in filament length. Furthermore, deficiency induced
spine degeneration was expected to reduce total spine numbers and spine density, while also
affecting the morphology of the spines. The change in spine morphology inflicted by deficiency
was hypothesized to cause a shift towards a more immature/degenerated state of the dendritic spines
with decreases in volume, area, diameter and shortening of the neck. Spine length could be increased
due to an increase of immature filopodia or decreased due to degeneration [54,55]. The descriptions of
the morphological parameters are based on descriptions in the Imaris manual provided by Bitplane.
Parameter Explanation Expected Outcome ofVitamin C Deficiency
Dendrite length The sum of the lengths of all dendrites on a neuron ↓
Dendrite diameter The mean diameter within a dendrite ↔ or ↓
Dendrite volume The volume of a dendrite ↔ or ↓
Branch numbers The number of dendrite branches on an neuron ↓
Spine number The number of spines on the entire neuron ↓
Spine density The number of spines per 10 µm dendrite ↓
Filament length The sum of dendrite length and spine length ↓
Spine length The length of the spines ↑ or ↓
Spine diameter The mean of the spine diameter ↓
Spine area The surface area of the spine ↓
Spine volume The volume of the spine ↓
Spine neck length The length of the spine neck ↓
Spine neck diameter The diameter of the spine neck ↓
Spine neck volume The volume of the spine neck ↓
2.8. Statistical Analysis
The data was analyzed in GraphPad Prism 7 (GraphPad Software, La Jolla, CA, USA) either by
repeated-measures two-way ANOVA, one-way ANOVA or Student’s t-test. Equality of variances
was assessed by the Brown-Forsythe test, while normal distribution was assessed by the D’Agostino
& Pearson normality test and histograms. In the event of nonhomogeneous variances, the data was
log-transformed or a nonparametric test was applied. Tukey’s or Dunn’s multiple comparisons test
were applied to correct for multiple comparisons in the biochemical and Western blotting data. Results
are presented as mean ± SD, or median (25%, 75% quartiles). A p-value < 0.05 was considered
statistically significant. As DHA% is calculated as (total vitC − Asc)/total vitC × 100 [48], DHA%
may—when close to zero—occasionally give rise to negative values. In this study, negative values
have been set to zero, while statistics have been performed on the original data to preserve normal
distribution and variance.
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3. Results
3.1. Animals
There was a significant impact of time and diet on the bodyweight (time p < 0.0001; diet p = 0.0436;
interaction p < 0.0001). The Sev_def group displayed mild growth retardation, when compared with
Ctrl from week 4 to week 8 (week 4, p = 0.0038; week 5, p = 0.0078; week 6, p = 0.0036; week 7, p = 0.0021;
week 8, p = 0.0170) but caught up in week 9 and 10 (Figure 3). At study termination, there was a
significant difference in the bodyweight of both Def and Sev_def compared to Ctrl (Def p = 0.0416;
Sev_def p = 0.0170).
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Figure 3. Changes in guinea pig bodyweight during the study. The Sev_def group showed mild growth
retardation from week 4, but caught up with Def animals by week 9. At termination, there was a
significant differe ce b twe n Ctrl and Def and Sev_d f. a Ctrl vs. Sev_def, p < 0.05; trl vs. Def,
p < 0.05. Two-way repeated-measur s ANOVA with Tukey’s multiple comparison c ti , n = 19,
mean ± SD. Ctrl: Control animals, Def: Vitamin C deficient animals, Sev_def: Severely vitamin C
deficient animals.
3.2. Biochemistry
As expected, the vitC levels in plasma reflected the respective diets of the groups (p < 0.0001):
the Def and Sev_def groups had si nificantly lower plasma levels than the Ctrl (p < 0.0001) (Table 2)
at euthanasia. The two defi ient g oups were also sign ficantly different from each other (Def vs.
Sev_def p < 0.0001). BH4 concentration in plasma was significantly higher in Ctrl than Def and Sev_def
(p < 0.0001), while Sev_def was significantly lower than Def (Def vs. Sev_def p = 0.031) (Table 2). This
was also reflected in the BH2/BH4 ratio, which was significantly lower in Ctrl animals compared to
Def and Sev_def (p < 0.0001), while there was no difference between the two deficiency groups. There
were no differences between the groups in plasma α- and γ-tocopherol and MDA (Table 2).
Dietary vitC intakes were also reflected in the vitC levels in the cerebral cortex: Sev_def levels
were lower than Def (p < 0.0001) and both Sev_def and Def levels were lower than Ctrl (p < 0.0001)
(Table 2). Despite eaching significant differences between groups (p < 0.0001), DHA% was consistently
very low and likely n gligible (Ctrl v . Sev_def p < 0.0001; Def vs. Sev_def p = 0.0413). No other
markers showe a y differences between the groups (Table 2).
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Table 2. Biochemical parameters of plasma, residual cortex and the adrenal glands.
Group/Marker Ctrl (n = 19) Def (n = 19) Sev_Def (n = 19) One-Way ANOVA orKruskal-Wallis Test
Plasma
VitC (µM) * 43.3 ± 8.5 a 4.4 ± 0.91 b 2.2 ± 0.46 c p < 0.0001
DHA (%) # 1.9 ± 2.0 3.0 ± 3.5 2.8 ± 3.5 NS
BH4 (nM) 68.3 ± 8.3 a 47.5 ± 10.1 b 40.4 ± 6.4 c p < 0.0001
BH2/BH4 œ 0.18(0.16; 0.22) a 0.31(0.25; 0.43) b 0.36(0.33; 0.41) b p < 0.0001
α-tocopherol (µM) 2.7 ± 0.8 2.5 ± 0.7 2.5 ± 0.7 NS
γ-tocopherol (µM) 0.1 ± 0.06 0.1 ± 0.05 0.09 ± 0.04 NS
MDA(µM) 1.0 ± 0.1 1.1 ± 0.2 1.1 ± 0.2 NS
Residual cerebralcortex
VitC (nmol/g) 1320 ± 254.6 a 753.2 ± 70.7 b 393.6 ± 91.3 c p < 0.0001
DHA (%) œ # 2.2(1.6; 2.6) 1.6(0.1; 1.9) b 0.0(0; 0.3) c p < 0.0001
GSH (nmol/g) 1244 ± 113.7 1247 ± 79.0 1244 ± 76.4 NS
GSSG (%) 3.7 ± 1.9 4.0 ± 1.8 3.9 ± 1.1 NS
SOD (U/g) 235 ± 54.0 232 ± 63.3 229 ± 79.9 NS
MDA (nmol/g) œ 165.9(135.1; 200.1) 169.5(140.7; 203.6) 200.8(152.5; 254.9) NS
α-tocopherol (nmol/g) 12.6 ± 3.1 11.9 ± 3.3 11.9 ± 1.6 NS
γ-tocopherol (nmol/g) 0.6 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 NS
Adrenal glands
VitC (nmol/g) 9571 ± 1951 a 3353 ± 1606 b 2554 ± 2344 b p < 0.0001
DHA (%) 3.5 ± 1.9 a 4.8 ± 2.0 a b 5.7 ± 2.1 b p = 0.0052
GSH (nmol/g) 1531 ± 107 a 1670 ± 172 b 1745 ± 180 b p = 0.0004
GSSG (%) 2.1 ± 1.5 1.8 ± 1.5 2.1 ± 1.7 NS
SOD (U/g) 180 ± 55.6 158 ± 52.0 173 ± 57.3 NS
Despite a clear influence of diet on vitamin C levels in plasma, cortex and adrenal glands, only the adrenal glands showed sign of increased oxidative stress. One-way ANOVA or
Kruskal–Wallis with Tukey’s or Dunn’s multiple comparison tests, n = 19, mean ± SD for parametric analysis, if non-parameteric: median (25%; 75% quartiles) are reported. * Denotes
log transformed data. œ Denotes nonparametric ANOVA. # Denotes truncated data. Different superscript letters denotes differences between groups. BH2: Dihydrobiopterin, BH4:
Tetrahydrobiopterin, Ctrl: Control animals, Def: Vitamin C deficient animals, DHA: Dehydroascorbate, GSH: Glutathione, GSSG: glutathione disulfide, MDA: Malondialdehyde (MDA),
NS: Not significant, Sev_def: Severely vitamin C deficient animals, SOD: Superoxide dismutase, VitC: Vitamin C. Tissue levels are shown as amount per gram tissue.
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In the adrenal glands, total vitC in Def and Sev_def were significantly lower (p < 0.0001), when
compared with Ctrl, but there was no difference between Def and Sev_def groups (Table 2). The DHA%
was significantly increased in Sev_def, when compared with Ctrl (p = 0.0038), while GSH was increased
in both Def and Sev_def (p = 0.0220 and p = 0.0003, respectively) (Table 2). No other markers showed
any differences between the groups.
3.3. ELISA and Western Blotting
The ELISA results of BDNF levels in FC, Hip and Stri are shown in Figure 4. No influence of
dietary vitC on BDNF was detected in any of the three brain areas. The same was evident for the
Western blotting results of synaptic plasticity markers: p- and synapsin 1, p- and CAMKII and their
respective ratios, where no differences due to vitC deficiency could be detected (Table 3).
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p-CAMKII 0.08 ± 0.05 0.05 ± 0.03 0.06 ± 0.03 NS 
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synapsin 1 1.74 ± 0.46 1.55 ± 0.41 1.51 ± 0.48 NS 
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synapsin 1 2.60 ± 0.92 2.23 ± 0.73 2.33 ± 0.37 NS 
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in any of the brain areas. One-way ANOVA with Tukey’s multiple comparison test, n = 10, mean ± 
SD. NS: Not significant. ND: Not detectable. -: Not determined. CAMKII: Ca2+-calmodulin-dependent 
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able 3. Synaptic plasticity arkers in the frontal cortex, hippoca pus and striatu .
Group/Marker Ctrl Def Sev_Def One-Way ANOVA
Frontal cortex
p-synapsin 1 0.64 ± 0.20 0.54 ± 0.15 0.52 ± 0.15 NS
synapsin 1 1.41 ± 0.41 1.66 ± 0.80 1.36 ± 0.51 NS
p-synapsin
1/synapsin 1 0.47 ± .11 0.41 ± 0.26 0.47 ± 0.29 NS
p-CAMKII 0.08 ± 0.05 0.05 ± 0.03 0.06 ± 0.03 NS
CAMKII 0.39 ± 0.07 0.38 ± 0.09 0.35 ± 0.05 NS
p-CAMKII/CAMKII 0.23 ± 0.13 0.14 ± 0.08 0. 8 ± 0.09 NS
Hippocampus
p-synapsin 1 1.24 ± 0.54 1.19 ± 0.74 1.11 ± 0.48 NS
synapsin 1 1.74 ± 0.46 1.55 ± 0.41 1.51 ± 0.48 NS
p-synapsin
1/synapsin 1 0.71 ± 0.26 0.77 ± 0.39 0.80 ± 0.43 NS
p-CAMKII 0.21 ± .12 0.17 ± 0.06 0.16 ± 0.05 NS
CAMKII 0.31 ± .09 0.33 ± 0.09 0.26 ± 0.09 NS
p-CAMKII/CAMKII 0.71 ± 0.40 0.56 ± 0.27 0.63 ± 0.20 NS
Striatum
p-synapsin 1 0.42 ± 0.09 0.41 ± 0.13 0.38 ± 0.10 NS
synapsin 1 2.60 ± 0.92 2.23 ± 0.73 2.33 ± 0.37 NS
p-synapsin
1/synapsin 1 0.18 ± 0.05 0.20 ± 0.11 0.17 ± 0.05 NS
p-CAMKII ND ND ND -
CAMKII 0.06 ± 0.04 0.06 ± 0.04 0.04 ± 0.04 NS
p-CAMKII/CAMKII - - - -
All values are in arbitrary units. No differences between groups were detected in any of the markers, in any of
the brain areas. One-way ANOVA with Tukey’s multipl comparison test, n = 10, mean ± SD. NS: Not significant.
ND: Not detectable. -: Not determined. CAMKII: Ca2+-calmodulin-dependent kinase II, Ctrl: Control animals,
Def: Vitamin C deficient animals, p-CAMKII: phosphorylated Ca2+-calmodulin-dependent kinase II, p-synapsin 1:
phosphorylated synapsin, Sev_def: Severely vitamin C deficient animals.
Nutrients 2018, 10, 749 10 of 18
3.4. Morphological Data
No differences between the Ctrl and Sev_def groups were detected in any of the morphological
parameters of the apical and the basal dendrites (Figure 5, Table 1), except for a slight decrease in apical
dendrite volume in the Sev_def group (p = 0.0488). The same was also the case for the Sholl analysis
(Figure 6), where severe vitC deficiency did not give rise to any regional changes in the dendrite arbor
for basal and apical dendrites.
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C deficient animals (apical—horisontal stripes; basal—white). No influence of vitamin C deficiency
was detected in the morphological parameters, except for a slight d crease in pical dendrite volume
(p = 0.0488). t-Test or Welch’s t-test, mean ± SD. Each experimental group consist d of 10 animals and
from each animal 5–7 pyramidal neurons situated within the st atum pyramidale of cornu ammonis 1
were analyzed for morphological changes and t e data averaged.
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4. Discussion 
The dietary vitC levels were reflected in the recorded plasma concentrations and cortical levels 
of the animals, as expected. A decrease in BH4 and an increase in BH2/BH4 ratio were evident in 
plasma of vitC deficient animals, reflecting that Asc is also a cofactor for the recycling of BH4 [17,50]. 
Though tissue BH4 levels were not measured in this study, the decreased BH4 in plasma may reflect 
a decrease in cerebral BH4 levels. Inside the brain, BH4 is involved in the synthesis of the 
monoaminergic neurotransmitters, e.g., dopamine and norepinephrine [19]. Dopaminergic neurons 
Figure 6. Sholl analysis of apical and basal dendrites of cornu ammonis 1 pyramidal neurons. Apical
(A) and basal (B) cornu ammonis 1 pyramidal neuron from control animals (black dots) and severely
vitamin C deficient animals (gray squares). No effect of vitC deficiency was detected on the dendrite
complexity measured as number of dendrite crossings on concentric circles radiating from the neuronal
soma with a continuous increase in the radius of 20 µm. Two-way repeated measures ANOVA, mean
± SD. Each experimental group consisted of 10 animals and from each animal 5–7 pyramidal neurons
within the stratum pyramidale of cornu ammonis 1 were analyzed for morphological changes and the
data averaged.
4. Discussion
The dietary vitC levels were reflected in the recorded plasma concentrations and cortical levels
of the animals, as expected. A decrease in BH4 and an increase in BH2/BH4 ratio were evident in
plasma of vitC deficient animals, reflecting that Asc is also a cofactor for the recycling of BH4 [17,50].
Though tissue BH4 levels were not measured in this study, the decreased BH4 in plasma may
reflect a decrease in cerebral BH4 levels. Inside the brain, BH4 is involved in the synthesis of the
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monoaminergic neurotransmitters, e.g., dopamine and norepinephrine [19]. Dopaminergic neurons
and receptors have been shown to be involved in spatial memory [56,57], while norepinephrine has
been found to be involved with memory consolidation and retrieval in the Hip [58,59]. Deviations in the
hippocampal monoamine levels could be a likely contributor to vitC imposed cognitive deficits. Indeed,
monoaminergic changes have been reported in a knockout mouse model of vitC deficiency [26,60].
Only limited changes in additional biochemical markers of redox balance were recorded.
The Sev_def group was included to assess effects of an increased degree of vitC deficiency
and subsequent progressive negative effects compared to Def animals, possibly indicating a
dose-dependency in the recorded markers. Dietary regimes similar to those applied in this study
have previously been shown to increase DHA%, as well as other markers of oxidative stress in guinea
pigs [20–22]. Contrary to our expectations, and despite a decrease in total vitC levels in the cerebral
cortex and an increase in the adrenal DHA% of the Def and Sev_def groups, the diets of the current
study did not impose a degree of deficiency in the brain severe enough to affect the additional redox
markers at time of euthanasia. Why this is the case remains speculative but may be due to the genetic
variation of the animals, as vitC homeostasis, and possibly also susceptibility to oxidative stress is
influenced by genetic differences [61–63]. Thus, it can be surmised that the animals in this study were
less susceptible to oxidative stress induced by low dietary vitC compared to previous studies. Still,
as vitC has several specific functions, low tissue levels could potentially affect the brain negatively.
The present absence of oxidative stress consequently allowed us to investigate a direct influence of
vitC deficiency on the BDNF pathway and the morphology of the CA1 pyramidal neurons.
However, since no differences between the experimental groups could be recorded in the markers
of synaptic plasticity, no direct impact of decreased vitC on synaptic plasticity can be supported by
this study. Consulting previously published findings, it is likely that oxidative stress is imperative
for vitC deficiency induced deficits [32,64]. Whether other cellular pathways are directly affected
by vitC deficiency remains to be investigated. However, BDNF affects down-stream targets through
three alternate routes; the phospholipase C-γ, the phosphoinositide-3 kinase and the extracellular
signal-regulated kinase (ERK) regulated pathway; all leading to transcription factor activation [33].
In vitro, Asc and SVCT2 overexpression have been shown to increase ERK 1/2 phosphorylation [37]
known to be important for long term spatial memory formation [65] and sensitive to oxidative stress [66].
Synapsin 1 has several phosphorylation sites, including one activated by ERK 1/2 [67]. Despite an
absence of changes in synapsin 1 phosphorylated at the CAMKII site as investigated in the current
study [68], it may be speculated that vitC deficiency would decrease ERK1/2 phosphorylation, in turn
decreasing presynaptic synapsin 1 phosphorylation and/or impaired postsynaptic transcription and
leading to the previously observed decreased spatial memory retention in early life guinea pigs [20].
Except for a slight decrease in apical dendrite volume, CA1 pyramidal neuron morphology
was not significantly different in severe vitC deficient animals compared to control counterparts.
This contrasts with previous studies investigating vitC and neuronal morphology. In vitro, cultures of
hippocampal neurons from SVCT2 knockout mice display decreased dendrite length and number of
primary branches [36], while overexpression of the transporter increased branching in neuroblastoma
cells [37], supporting that neuronal morphology, in vitro, is influenced by vitC uptake. In vivo, findings
from adult Gulo−/− mice further associates total vitC depletion with atrophic neuronal changes,
including axonal and dendritic shrinkage in the granule and Purkinje neurons of the cerebellum,
in conjunction with increases in oxidative stress, apoptotic markers and inflammation [32]. Other forms
of malnutrition, both pre-and postnatal, have been found to alter neuronal morphology in the Hip,
supporting that the hippocampal dendritic arbor is sensitive to malnutrition states during development;
e.g., iron deficiency inducing reduced CA1 pyramidal neurons dendrite width, spine head diameter
and branching, [69], a high fat diet giving rise to decreased dendrite length and branch points as well
as indications of decreased spines in basal CA1 pyramidal neurons [70], and iodine deficiency showing
decreases in the length and number of basal dendrites [71]. This links malnutrition to deviations in
early life development of neuronal and dendrite morphology, promoting neurological deficits with
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putatively negative consequences for brain function i.e., memory deficits [72,73] We hypothesized
that vitC deficiency in early life would impose a detrimental effect on overall neuronal morphology,
measured as a reduction in dendrite length and branching and an immature or degenerative dendritic
spine morphology with alterations in length and reductions in volume and/or area (Table 1) [54,55].
Contrary to our hypothesis, but in line with the protein expression analysis on the included brain
samples, no alterations of the measured morphological target points were recorded in the current
study. Decreased spine density and dendrite length in CA1 has been shown in induced brain-oxidative
stress in vivo [74,75] and in animal models of Alzheimer’s disease [76,77], known to display increased
oxidative stress during disease progression [78], supporting the association between oxidative stress
and impaired CA1 morphology. The absence of morphological differences between experimental
groups in the current groups, suggests that vitC deficiency in the brain may require the presence of
redox imbalance to impose negative effects on neuronal morphology.
Other subareas and cell types in the Hip are involved in spatial memory and may also be targets
of its deficiency-associated memory deficits. The CA1 area selected for the present investigation
represents a subdivision of the Hip and the reported absence of altered neuronal morphology does
not exclude a vitC deficiency-imposed effect on other areas of the Hip, e.g., the CA3 and dentate
gyrus. CA3 pyramidal neurons are involved in retention of spatial memory and in spatial memory
recall [79,80], while neurogenesis in the dentate gyrus has also been found to be crucial in spatial
memory [81,82]. Whether other hippocampal areas are affected by vitC deficiency remains to be
explored. Other cell types within the brain may also be sensitive to vitC deficiency. Astrocytes are
key cells in regulation of oxidative stress in the brain and recycle Asc from DHA [83]. They have been
shown to influence neurotransmission, synaptic plasticity, learning and memory [84,85] and increased
oxidative stress has been found to induce astrocyte dysfunction [86,87]. Astrocytes secrete Asc, when
stimulated by glutamate [88], which may be crucial in preventing excitotoxicity otherwise leading
to increased neuronal death [36]. Interestingly, increased oxidative stress decreases accumulation of
recycled Asc in astrocytes [89], which may lead to increased glutamate-induced excitotoxicity. Indeed,
we have previously found lower number of neurons in the Hip in vitC deficient guinea pigs [20]. Thus,
disturbances in astrocyte function and impairment of glutamate regulation could be detrimental to the
brain and should be investigated further.
5. Conclusions
In conclusion, vitC deficiency without ensuing oxidative stress does not seem to decrease synaptic
plasticity or CA1 neuronal morphology in young guinea pigs. Other pathways potentially involved
with vitC deficiency induced spatial memory deficits should be investigated.
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